126 related articles for article (PubMed ID: 22526163)
1. Role of the functional MKK4 promoter variant (-1304T>G) in a decreased risk of prostate cancer: case-control study and meta-analysis.
Shao N; Wang Y; Lu K; Jiang WY; Li Q; Wang N; Feng NH; Hua LX
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1531-9. PubMed ID: 22526163
[TBL] [Abstract][Full Text] [Related]
2. A functional variant (-1304T>G) in the MKK4 promoter contributes to a decreased risk of lung cancer by increasing the promoter activity.
Liu B; Chen D; Yang L; Li Y; Ling X; Liu L; Ji W; Wei Y; Wang J; Wei Q; Wang L; Lu J
Carcinogenesis; 2010 Aug; 31(8):1405-11. PubMed ID: 20554746
[TBL] [Abstract][Full Text] [Related]
3. The association between -1304T>G polymorphism in the promoter of mitogen-activated protein kinase kinase 4 gene and the risk of cervical cancer in Chinese population.
Hu M; Zheng J; Zhang L; Jiang L; You Y; Jiang M; Li H
DNA Cell Biol; 2012 Jul; 31(7):1167-73. PubMed ID: 22335172
[TBL] [Abstract][Full Text] [Related]
4. The association between -1304T>G polymorphism in the promoter of MKK4 gene and the risk of sporadic colorectal cancer in southern Chinese population.
Wei Y; Wang L; Lan P; Zhao H; Pan Z; Huang J; Lu J; Wang J
Int J Cancer; 2009 Oct; 125(8):1876-83. PubMed ID: 19610067
[TBL] [Abstract][Full Text] [Related]
5. Functional variant (-1304T>G) in the MKK4 promoter is associated with decreased risk of acute myeloid leukemia in a southern Chinese population.
Jiang L; Zhou P; Sun A; Zheng J; Liu B; You Y; Zhang C; Wu D; Zhou Y
Cancer Sci; 2011 Aug; 102(8):1462-8. PubMed ID: 21518142
[TBL] [Abstract][Full Text] [Related]
6. [Association between MKK4 promoter-1304T/G polymorphism and genetic susceptibility in sporadic nasopharyngeal carcinoma].
Lu M; Kong Q; Xu X; Lu H; Lu Z; Shi K; Xu B; Guo R
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Feb; 30(4):287-90. PubMed ID: 27373035
[TBL] [Abstract][Full Text] [Related]
7. The protective role of polymorphism MKK4-1304 T>G in nasopharyngeal carcinoma is modulated by Epstein-Barr virus' infection status.
Zheng J; Liu B; Zhang L; Jiang L; Huang B; You Y; Jiang Q; Zhang S; Lu J; Zhou Y
Int J Cancer; 2012 May; 130(9):1981-90. PubMed ID: 21702039
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the association between the -1304T>G polymorphism in the promoter of the
Bai R; Yuan C; Zhou F; Ni L; Gong Y; Xie C
Ann Transl Med; 2019 Apr; 7(7):144. PubMed ID: 31157265
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-Activated Protein Kinase Kinase 4 Gene Polymorphism and Cancer Risk.
Geng P; Ou J; Xie G; Li J; Zhao X; Xiang L; Liao Y; Wang N; Liang H
Medicine (Baltimore); 2015 Nov; 94(44):e0938. PubMed ID: 26554761
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of Metastasis Suppressor Genes MKK4 and NME1 in Kashmiri Patients with Breast Cancer.
Iqbal B; Masood A; Lone MM; Lone AR; Dar NA
Breast J; 2016 Nov; 22(6):673-677. PubMed ID: 27509166
[TBL] [Abstract][Full Text] [Related]
11. Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study.
Chen J; Cui X; Zhou H; Qin C; Cao Q; Ju X; Li P; Cai H; Zhu J; Meng X; Wang M; Zhang Z; Shao P; Li J; Yin C
BMC Cancer; 2013 Jul; 13():356. PubMed ID: 23883402
[TBL] [Abstract][Full Text] [Related]
12. Role of the functional variant (-652T>G) in the XRCC4 promoter in prostate cancer.
Shao N; Li J; Xu B; Wang Y; Lu X; Feng N
Mol Biol Rep; 2014 Nov; 41(11):7463-70. PubMed ID: 25096509
[TBL] [Abstract][Full Text] [Related]
13. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.
Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T
Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677
[TBL] [Abstract][Full Text] [Related]
14. Association of caspases with an increased prostate cancer risk in north Indian population.
Mittal RD; Mittal T; Singh AK; Mandal RK
DNA Cell Biol; 2012 Jan; 31(1):67-73. PubMed ID: 21668377
[TBL] [Abstract][Full Text] [Related]
15. A regulatory polymorphism at position -309 in PTPRCAP is associated with susceptibility to diffuse-type gastric cancer and gene expression.
Ju H; Lim B; Kim M; Kim YS; Kim WH; Ihm C; Noh SM; Han DS; Yu HJ; Choi BY; Kang C
Neoplasia; 2009 Dec; 11(12):1340-7. PubMed ID: 20019842
[TBL] [Abstract][Full Text] [Related]
16. A functional polymorphism in the CYR61 (IGFBP10) gene is associated with prostate cancer risk.
Tao L; Chen J; Zhou H; Qin C; Li P; Cao Q; Li J; Ju X; Zhu C; Wang M; Zhang Z; Shao P; Yin C
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):95-100. PubMed ID: 23045290
[TBL] [Abstract][Full Text] [Related]
17. Positive association between vascular endothelial growth factor (VEGF) -2578 C/A variant and prostate cancer.
Martinez-Fierro ML; Garza-Veloz I; Rojas-Martinez A; Ortiz-Lopez R; Castruita-de la Rosa C; Ortiz-Castro Y; Lazalde-Ramos BP; Cervantes-Villagrana AR; Castañeda-Lopez ME; Gomez-Guerra L; Delgado-Enciso I; Martinez-Torres AA
Cancer Biomark; 2013; 13(4):235-41. PubMed ID: 24240584
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 promoter variants, prostate cancer risk, and survival.
Tindall EA; Severi G; Hoang HN; Southey MC; English DR; Hopper JL; Giles GG; Hayes VM;
Prostate; 2012 Dec; 72(16):1701-7. PubMed ID: 22782910
[TBL] [Abstract][Full Text] [Related]
19. Functional promoter rs2295080 T>G variant in MTOR gene is associated with risk of colorectal cancer in a Chinese population.
Xu M; Gao Y; Yu T; Wang J; Cheng L; Cheng L; Cheng D; Zhu B
Biomed Pharmacother; 2015 Mar; 70():28-32. PubMed ID: 25776475
[TBL] [Abstract][Full Text] [Related]
20. Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese.
Liu J; Song B; Bai X; Liu W; Li Z; Wang J; Zheng Y; Wang Z
BMC Cancer; 2010 Aug; 10():456. PubMed ID: 20735825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
